RESUMO
Depression is one of the most economically burdensome diseases with serious consequences for patients as well as their families. Many depressed patients are not treated because they neither contact a doctor nor are diagnosed correctly. Today, it is generally accepted that depression is not just one disease but is composed of subgroups, each requiring its own specific treatment. In mild to moderate depression SSRIs or other newer antidepressants can be used but in cases of severe melancholic or psychotic depression TCAs or ECT are the treatments of choice.
Assuntos
Depressão/terapia , Transtorno Depressivo/terapia , Antidepressivos/uso terapêutico , Antidepressivos Tricíclicos/uso terapêutico , Depressão/diagnóstico , Depressão/tratamento farmacológico , Transtorno Depressivo/diagnóstico , Transtorno Depressivo/tratamento farmacológico , Eletroconvulsoterapia , Tratamento de Emergência , Humanos , Inibidores Seletivos de Recaptação de Serotonina/uso terapêuticoRESUMO
Depression is an independent risk factor for ischemic heart disease and is related to increased cardiovascular mortality. Post myocardial infarction depression is related to less compliance with medical treatment, less participation in cardiac rehabilitation, less modification of life style factors and increased mortality. So far, routine treatment with selective serotonin re-uptake inhibitors is not warranted as the evidence is insufficient. Improved cooperation between general practice, cardiologists and psychiatrists is necessary in order to identify and treat this group of patients.